Introduction
============

Total hip and knee arthroplasty (THA and TKA) are well-proven solutions in case of end-stage osteoarthritis of hip and knee [@B1]-[@B5]. Although, presence of complications can be devastating for the patient, especially periprosthetic joint infection (PJI) [@B6]-[@B8]. To prevent PJI, antibiotic prophylaxis regimens are regularly used [@B7], [@B9]-[@B11]. Since the introduction of systemic and local antibiotic prophylaxis in primary THA and TKA the percentage of infectious complications has decreased to 1-2% of these arthroplasty patients [@B7]. A major part of PJI are caused by Staphylococcus species, particularly Staphylococcus (S.) aureus and coagulase negative staphylococci (CoNS) [@B6], [@B12]. Generally these bacteria are susceptible to cephalosporins such as cefazolin or cefuroxime [@B13].

The numbers of yearly performed THA and TKA are expected to increase.[@B14] Therefore the absolute number of infectious complications will likely increase as well, even when the percentage of infections can be limited further. Evidence based guidelines for the treatment of PJI are needed to face this challenge [@B15].

A worldwide consensus meeting concerning prevention, diagnosis and treatment of periprosthetic joint infections held in 2013 suggested antibiotic prophylaxis to be discontinued within 48 hours postoperatively.[@B10], [@B16], [@B17] A recently updated guideline by the Netherlands Orthopaedic Association (NOV) advises an antibiotic prophylaxis to be discontinued within 24 hours after surgery.[@B18] Continuation of antibiotic prophylaxis for more than 24 hours postoperatively does not provide lower infection rates.[@B19]

The duration of systemic antibiotic prophylaxis and the type of antibiotic used remain subject of discussion. The aforementioned consensus meeting suggests a first- or second-generation cephalosporin as antibiotic of first choice.[@B16] The same was recommended in the recently updated guideline of the NOV.[@B18] A recent study performed in Great Britain revealed a wide variety of types of antibiotics used, without region-specific bacterial occurrence to account for differences in treatment.[@B20] This variety in treatment protocols may be caused by the absence of a national antibiotic prophylaxis guideline for all National Health Service Trusts in the UK.[@B20] The optimal duration of antibiotic prophylaxis remains undetermined.

In case of early infection after total hip or knee arthroplasty management with a debridement, antibiotics and implant retention (DAIR) procedure is the first treatment of choice [@B21]. According to the Dutch Arthroplasty Register (LROI) these procedures should be registered in the database as a revision procedure. Several studies of the National Joint Registries in Sweden, Denmark and Norway suggest about 30-40% of PJI and DAIR-procedures are not reported in national databases [@B22]-[@B25].

Underreporting of infections in implant registries is likely to be caused by the design of these databases which is not adequate for registry of infections, as the reason for revision is registered preoperatively while the diagnosis of infection can only be made after results of preoperatively taken tissue cultures are complete 2-7 days later.[@B22] Chronic infections which are treated with antibiotic suppression therapy are also not registered in implant registries.

This study was performed to evaluate the use of standardized protocols on systemic antibiotic prophylaxis for primary THA and TKA in The Netherlands. Second, this study evaluated protocols concerning DAIR procedures and the tendency to register DAIR-procedures in the database by Dutch orthopaedic institutions. We hypothesized that, in contrast with British practice, little variety in type of antibiotics and variation in duration of antibiotic prophylaxis would exist in The Netherlands. Secondly, we hypothesized that not all DAIR treatments are performed according to a set protocol and that DAIR procedures are under-reported in the LROI.

Methods
=======

A list of institutions performing THA and/or TKA was retrieved from the LROI annual report 2014 [@B26]. In each institution an orthopaedic surgeon was selected, who was specialised in either knee or hip arthroplasty. An electronic 16-question survey ([Supplementary Material](#SM0){ref-type="supplementary-material"}) concerning the perioperative protocol for THA and TKA was constructed and sent to the selected orthopaedic surgeons. Non-responding institutions were contacted by telephone and the survey was taken from the attending orthopaedic surgeon to assure an optimal response rate. During the period of May through July 2016 a total of ninety-nine university hospitals, teaching and regional hospitals and private orthopaedic clinics were included.

Data management and analysis were performed with SPSS 2016 software.

Results
=======

All ninety-nine contacted institutions completed the questionnaire. All responders were orthopaedic surgeons, practicing in eight university hospitals, eighty general hospitals and eleven private orthopaedic clinics.

Systemic antibiotic prophylaxis
-------------------------------

A protocol describing perioperative care including systemic antibiotic prophylaxis was present in all but one institution. In eighty-nine institutions, multiple doses of antibiotic prophylaxis were administered (three or four doses in case of cefazolin, three doses in case of cefuroxime) within twenty-four hours postoperatively. Antibiotic prophylaxis was limited to a single preoperative administration in ten institutions (Figure [1](#F1){ref-type="fig"}). Antibiotic of choice was cefazolin in ninety-four institutions. Four institutions administered cefuroxime as antibiotic prophylaxis, one institution administered one shot of cefazolin preoperatively and two shots of cefuroxime postoperatively. Allergy for cephalosporins or proven colonization with multi-resistant micro-organisms were reported as reason for alternative prophylaxis, in which the recommendations of the international consensus meeting were followed and either clindamycin or vancomycin were administered as second-choice antibiotic.

Infection treatment: Hip
------------------------

Seventy-one institutions have a protocol describing the treatment for patients with suspected early periprosthetic joint infection of the hip. When a debridement, antibiotics and implant retention (DAIR) procedure is performed, modular parts are exchanged in sixty-six institutions (Figure [2](#F2){ref-type="fig"}). Eight institutions reported only to exchange the femoral head, but not the acetabular liner. In four of these institutions, this was motivated by the use of a monoblock acetabular component. Three institutions only exchanged modular parts in case a second DAIR procedure was performed. In twenty-two institutions, modular parts are not exchanged during DAIR. Although many institutions exchange modular parts, DAIR procedures are registered in the LROI by only sixty-three institutions.

Infection treatment: Knee
-------------------------

Seventy-three institutions have a protocol describing the treatment for patients with suspected early periprosthetic joint infection of the knee. When a DAIR procedure is performed, the insert is exchanged in eighty-one institutions, the insert is not exchanged in the remaining eighteen institutions (Figure [2](#F2){ref-type="fig"}). DAIR procedures are registered in the LROI by sixty-three institutions.

Discussion
==========

Duration of systemic antibiotic prophylaxis remains a topic of discussion. First, we hypothesized that little variety in antibiotic prophylaxis protocols concerning primary total hip and knee arthroplasty would exist in The Netherlands. This hypothesis was correct. With all but one institutions stating the presence of a protocol for antibiotic prophylaxis in primary total hip and knee arthroplasty the authors believe this is an excellent basis for optimal prophylactic treatment in total hip and knee joint arthroplasty surgery. National and worldwide guidelines for administration of cephalosporin as antibiotic prophylaxis were followed by all Dutch institutions. The incidence of MRSA in the Netherlands is relatively low comparing to other European countries [@B12], [@B12], [@B27], [@B28]. Therefore a prophylaxis regimen with only a cephalosporin is sufficient [@B12], [@B27].

Duration of antibiotic prophylaxis primary total joint arthroplasty surgery in The Netherlands is twenty-four hours in 89 out of 99 institutions. In 10 out of 99 institutions antibiotic prophylaxis consists of a single preoperative shot. Engesaeter and colleagues have found less infection and aseptic loosening after multiple shot antibiotic prophylaxis compared to single shot antibiotic prophylaxis in their observational study [@B19]. Up to date insufficient evidence is available to favour either one of these protocols.

The cornerstone in the treatment of PJI should be evidence based treatment protocols [@B16]. Protocolled care is expected to minimise the chance of errors during treatment [@B16], [@B29]. Availability of such local protocols when suspecting PJI is 71 and 73 out of 99 institutions for hip and knee arthroplasties respectively in The Netherlands. The Netherlands Orthopaedic Association (NOV) has recently updated its treatment recommendations in presence of PJI [@B29]. The NOV recommendation suggests exchange of all modular parts of a total joint implant in case a DAIR procedure is performed. This is in concordance with the recommendations of the international consensus meeting.[@B16] Exchange of modular parts during a DAIR procedure is performed in seventy-four of ninety-nine institutions in case of the hip and in eighty-one of ninety-nine institutions in case of the knee. Registration of DAIR procedure is mandatory according to the LROI instructions on registration of revision procedures (i.e. registration would be done in case of an exchange of any implant). However, DAIR procedures are registered in the LROI by only sixty-four percent of the institutions. This means that currently there is a significant under registration, with consequently a potential underestimation of the rate of implant-related infections in our nationwide joint registry. It should be taken into account that a DAIR is also performed for prolonged wound drainage after a primary joint arthroplasty and is thus not always identical to a PJI. The possibility to register a DAIR procedures as such instead of as a partial revision may lead to improved registration of these procedures, especially in hospitals where modular parts are not exchanged during DAIR. Nevertheless, registration of DAIR procedures require better attention. First to relate DAIR procedures to primary surgery, secondly to relate them to (suspected) early and late infections resulting in implant removal. The latter can be early or late after the initial DAIR procedure, these data can then be used as part of a quality surveillance systems to improve patient care.

Weaknesses of this study are caused by its design, a questionnaire survey. Despite presence of a protocol, still differences between orthopaedic surgeons within the same institute might occur, the latter cannot be accounted for in this study. But since prevention of a PJI by antibiotic prophylaxis is common practice, the likelihood of not conferring to the prophylaxis protocol is highly unlikely. As for DAIR procedures, larger inter-surgeon variation may exist. Due to the present form of the LROI registry it has a reporting bias for PJI, which makes it difficult to draw conclusions concerning postoperative infections.

We have managed to achieve an excellent response rate, which is a pearl of this study. This study provides a perspective on the use of current prophylactic regimes and availability of protocolled care in The Netherlands. Also, the availability and characteristics of protocols describing treatment when suspecting early infection after primary hip or knee prosthesis are evaluated.

With the number of primary prosthesis expected to increase in years to come, the orthopaedic society faces a tremendous challenge. Even if the percentage of infectious complications can be decreased, the absolute number of PJI is likely to increase drastically. To cope with this challenge, research studying the optimal prevention of infectious complications, of which is also DAIR in presence of persistent wound leakage, following total hip or knee arthroplasty is crucial. Future research should show which type and duration of antibiotic prophylaxis regime provides lowest risk for infection after primary total hip or knee arthroplasty.
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